文献速递外周动脉疾病

衰弱对重症肢体缺血患者血运重建后结局的影响

Influence of frailty on treatment outcomes after revascularization in patients with critical limb ischemia.
PubMed 文献 · J Vasc Surg · 2017-06-21

该回顾性研究纳入2007至2015年接受膝下血运重建的266例患者(325条肢体),以CLI衰弱指数(含低老年营养风险指数、低骨骼肌质量指数或无法行走中≥2项)定义衰弱。结果显示衰弱组2年无截肢生存率显著低于非衰弱组,且CLI衰弱指数为2年无截肢生存、并发症及30天/住院死亡的独立危险因素。

要点

  • CLI衰弱指数(≥2项:低GNRI、低SMI、无法行走)可预测血运重建后不良结局。
  • 衰弱组2年无截肢生存率仅34.0%,显著低于非衰弱组的72.9%。
  • CLI衰弱指数对2年无截肢生存的预测AUC为0.72,优于改良衰弱指数。

核心结论

  • CLI衰弱指数是重症肢体缺血患者血运重建后2年无截肢生存的危险因素。
  • 该指数有助于预后预测及选择旁路手术或血管内治疗作为首选策略的决策。

研究设计与样本

  • 回顾性分析2007至2015年接受膝下血运重建的266例患者、325条肢体。
  • 衰弱定义为低老年营养风险指数、低骨骼肌质量指数或无法行走中≥2项。

主要发现

  • 衰弱组与非衰弱组1年无截肢生存率分别为45.8%与81.8%,2年分别为34.0%与72.9%(P < .001)。
  • 多因素分析显示CLI衰弱指数(HR 2.77,95%CI 1.78-4.32,P < .001)和血液透析(HR 1.72,95%CI 1.11-2.69,P = .02)为2年无截肢生存的危险因素。
  • CLI衰弱指数是并发症(HR 3.21,95%CI 1.45-7.27,P = .004)和30天或住院死亡(HR 6.32,95%CI 1.43-43.7,P = .01)的危险因素。
  • CLI衰弱指数AUC为0.72,改良衰弱指数AUC为0.63(P = .01)。

关键数值与推荐

  • CLI衰弱判定标准:低老年营养风险指数、低骨骼肌质量指数或无法行走中≥2项。
  • 主要终点为2年无截肢生存率,次要终点为Clavien-Dindo IV级并发症及30天或住院死亡。

临床怎么用

  • 对拟行血运重建的CLI患者,可采用CLI衰弱指数评估衰弱状态以预测预后。
  • 衰弱评估结果可辅助选择旁路手术或血管内治疗作为首选策略。

局限性

  • 回顾性研究设计。
  • 单中心研究,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It is unclear whether frailty adversely affects treatment outcomes in patients with critical limb ischemia (CLI). The aim of this study was to investigate the influence of frailty on CLI patients after revascularization. METHODS: Patients undergoing infrapopliteal revascularization between 2007 and 2015 were retrospectively analyzed. The patient was defined as CLI frail when two or more of the following were present: low Geriatric Nutritional Risk Index, low skeletal muscle mass index, or nonambulatory status. The primary study end point was 2-year amputation-free survival (AFS). To analyze the diagnostic criteria of frailty, the CLI Frailty Index was compared with a modified Frailty Index using a receiver operating characteristic area under the curve. The secondary end points were occurrence of Clavien-Dindo class IV complications and 30-day or hospital mortality. RESULTS: During the study period, 266 patients and 325 limbs underwent infrapopliteal revascularization. The AFS rate 1 year and 2 years after revascularization was 81.8% and 72.9% for the CLI frail- group vs 45.8% and 34.0% for the CLI frail+ group (P < .001), respectively. Multivariate analysis revealed that the CLI Frailty Index (hazard ratio [HR], 2.77; 95% confidence interval [CI], 1.78-4.32; P < .001) and hemodialysis (HR, 1.72; 95% CI, 1.11-2.69; P = .02) were risk factors for AFS 2 years after revascularization. The CLI Frailty Index area under the curve was 0.72 compared with 0.63 for the modified Frailty Index (P = .01). Only the CLI Frailty Index was found to be a risk factor for morbidity (HR, 3.21; 95% CI, 1.45-7.27; P = .004) and 30-day or hospital mortality (HR, 6.32; 95% CI, 1.43-43.7; P = .01). CONCLUSIONS: The CLI Frailty Index is a risk factor for 2-year AFS in CLI patients after revascularization. This result could prove useful for prognostic prediction and decision-making in selection of bypass surgery or endovascular therapy as a first treatment strategy.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Morisaki K, Yamaoka T, Iwasa K, et al. Influence of frailty on treatment outcomes after revascularization in patients with critical limb ischemia. J Vasc Surg. 2017. PMID: 28647199. doi:10.1016/j.jvs.2017.04.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。